Advitech Inc. (TSX VENTURE: AVI) announces that pursuant to the Company's stock option plan, it has granted a total of 189,000 stock options to its directors. These options have an exercise price of $0.20 per share and are valid for a period of five (5) years.
This grant of options is subject to regulatory approval.
About Advitech Inc.
Advitech is a health sciences and technology company with a mission to discover and commercialize proprietary and evidence-based natural health products. Effective and safe, these products play a role in the prevention of Immune-Mediated Inflammatory Disorders (IMID), such as psoriasis and inflammatory bowel disease. Advitech's common shares are listed on the TSX Venture Exchange under the symbol AVI. The number of common shares outstanding is 72 965 051.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.